BioSpace News Archive

Press Releases

NovaBay CEO Letter to Stockholders Urges a FOR Vote at Upcoming Reconvened Special Meeting

December 9, 2024
·
9 min read
Press Releases

FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

December 9, 2024
·
9 min read
Press Releases

Solu Therapeutics Presents Positive Preclinical Data on STX-0712 for Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting

December 9, 2024
·
3 min read
Press Releases

Seismic Therapeutic Presents New Preclinical Efficacy Data for S-1117 in Prophylactic and Therapeutic Animal Models of Immune Thrombocytopenia (ITP) at 66th ASH Annual Meeting

December 9, 2024
·
3 min read
Press Releases

Datopotamab deruxtecan granted breakthrough therapy designation in US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

December 9, 2024
·
10 min read
Press Releases

Relmada Therapeutics to Discontinue the Reliance II and Relight Phase 3 Studies of REL-1017

December 9, 2024
·
4 min read
Press Releases

ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma

December 9, 2024
·
9 min read
Press Releases

Concord Healthcare Announces Approval Granted to the Application for the Proton Therapy Equipment Registration Certificate

December 9, 2024
·
3 min read
Press Releases

Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly

December 9, 2024
·
8 min read
Press Releases

Actinogen randomizes first US participant in XanaMIA phase 2b/3 Alzheimer’s disease trial

December 9, 2024
·
9 min read